학술논문

LONG-TERM REMISSION OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH AS-NEEDED ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY
Document Type
article
Source
Retina. 38(3)
Subject
Biomedical and Clinical Sciences
Ophthalmology and Optometry
Neurodegenerative
Neurosciences
Macular Degeneration
Clinical Research
Eye Disease and Disorders of Vision
Aging
Eye
Aged
Aged
80 and over
Angiogenesis Inhibitors
Bevacizumab
Case-Control Studies
Choroidal Neovascularization
Female
Humans
Intravitreal Injections
Male
Middle Aged
Receptors
Vascular Endothelial Growth Factor
Recombinant Fusion Proteins
Vascular Endothelial Growth Factor A
Wet Macular Degeneration
age-related macular degeneration
anti-vascular endothelial growth factor
pro re nata
as needed
remission
long-term remission
optical coherence tomography
Opthalmology and Optometry
Ophthalmology & Optometry
Ophthalmology and optometry
Language
Abstract
PurposeTo determine the presenting characteristics of patients with neovascular age-related macular degeneration with long-term remission (LTR), which was defined as the absence of intraretinal/subretinal fluid, or hemorrhage, and absence of leakage on fluorescein angiography for longer than 6 months while on as-needed antivascular endothelial growth factor treatment.MethodsThe presenting characteristics of patients with LTR were compared with a control group including 32 eyes of 28 age-, gender-, and ethnicity-matched patients who did not achieve LTR.ResultsSeventy-four percent of patients in the LTR group had Type 1 choroidal neovascular membrane and 18.5% had retinal angiomatous proliferation. In the control group, 28 eyes had Type 1 choroidal neovascular membrane (87.5%), and none of the patients had retinal angiomatous proliferation; overall, there was a significant difference in lesion types between the 2 groups (P = 0.036). Eyes with LTR at presentation had significantly thinner subfoveal choroidal thickness (147 vs. 178 μm, P = 0.04). There was more intraretinal fluid and less subretinal fluid at the presentation in the remission group (59.3% intraretinal fluid and 11.1% subretinal fluid) compared with the control group (28.1% intraretinal fluid and 34.4% subretinal fluid, P = 0.03).ConclusionThe presence of retinal angiomatous proliferation, thinner choroidal thickness, more intraretinal fluid, and less subretinal fluid at presentation were associated with LTR in patients receiving as-needed treatment for age-related macular degeneration.